HSPB1 and breast cancer: Hsp27, Hsp60, Hsp70, and Hsp90 are promoters of tumorigenesis in BC and are implicated in pathogenic mechanisms underpinning invasiveness, epithelial-mesenchymal transition (EMT), metastasization, and resistance to therapy [13].